Nanotechnology and CSC Targeting
Nanotechnology offers a promising approach for selectively targeting cancer stem cells (CSCs) with greater precision. This track focuses on the development of nanoparticle-based drug delivery systems that can specifically target CSCs while minimizing damage to normal cells. Researchers explore how nanoparticles can be engineered to deliver therapeutic agents directly to CSCs by recognizing specific surface markers or responding to the unique microenvironment of CSCs. Nanotechnology also enables the delivery of combination therapies, such as chemotherapy and immunotherapy, to effectively eliminate CSCs and prevent tumor recurrence. This research holds the potential to revolutionize cancer treatment by improving the specificity and efficacy of CSC-targeted therapies.
Related Conference of Nanotechnology and CSC Targeting
April 21-22, 2025
16th International Conference on Cancer Stem Cell & Oncology Research
Amsterdam, Netherlands
October 13-14, 2025
8th International Conference on Anti-Cancer Drugs & Therapies
Aix-en-Provence, France
November 24-25, 2025
47th Euro-Global Summit on Cancer Therapy & Radiation Oncology
Barcelona, Spain
Nanotechnology and CSC Targeting Conference Speakers
Recommended Sessions
- CRISPR/Cas9 in CSC Research
- CSC and Immunoediting
- CSC Biomarkers for Early Detection
- CSC Fate Determination and Differentiation
- CSC Heterogeneity in Tumors
- CSC Metabolism and Energy Pathways
- CSC Niche and Hypoxia
- CSC Plasticity and Tumor Progression
- CSC-Derived Exosomes and Communication
- CSC-Driven Angiogenesis
- CSC-Driven Resistance to Radiotherapy
- CSC-Mediated Immunosuppression
- CSCs and Tumor Microenvironment
- Drug Resistance Mechanisms in CSCs
- Epigenetics and CSC Regulation
- Immunotherapy and CSCs
- Inflammation and CSC Activation
- Molecular Signaling in CSCs
- Nanotechnology and CSC Targeting
- Natural Products and CSC Targeting
- Role of CSCs in Metastasis
- Role of EMT in CSC Plasticity
- Targeting CSC Dormancy
- Targeting CSC-Specific Surface Markers
- Therapy Resistance and CSCs
Related Journals
Are you interested in
- Advances in Cancer Prevention and Risk Assessment - Preventive Oncology 2025 (Italy)
- AI and Machine Learning in Cancer Care - CANCER2025 (Netherlands)
- Alternative Treatment and Cancer Therapy - Cancer Research 2025 (Spain)
- Anti-Cancer Drug Discovery and Development - Cancer Research 2025 (Spain)
- Artificial Intelligence in Cancer Research - CANCER BIOLOGY- 2025 (Italy)
- Biomarkers and Liquid Biopsy - CANCER BIOLOGY- 2025 (Italy)
- Breast Cancer - Breast Cancer Summit 2025 (Italy)
- Breast Cancer - Cancer Meeting Summit 2025 (France)
- Breast cancer and cell biology - Breast Cancer Summit 2025 (Italy)
- Breast Cancer and Cell Biology - Breast Cancer 2025 (Italy)
- Breast Cancer And Immunology - Breast Cancer Summit 2025 (Italy)
- Breast Cancer and Immunology - Breast Cancer 2025 (Italy)
- Breast Cancer Awareness - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Awareness - Breast Cancer 2025 (Italy)
- Breast Cancer Clinical Trials - Breast Cancer 2025 (Italy)
- Breast Cancer Detection, Prevention and Diagnosis - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Detection, Prevention, and Diagnosis - Breast Cancer 2025 (Italy)
- Breast Cancer during pregnancy - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Management - Breast Cancer 2025 (Italy)
- Breast Cancer Nursing - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Nursing - Breast Cancer 2025 (Italy)
- Breast Cancer Radiation Therapy - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Risk - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Risk - Breast Cancer 2025 (Italy)
- Breast Cancer Staging - Breast Cancer 2025 (Italy)
- Breast cancer surgery - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Surgery - Breast Cancer 2025 (Italy)
- Breast Cancer Therapies - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Types and Etiology - Breast Cancer 2025 (Italy)
- Breast Cancer- Clinical Trails - Breast Cancer Summit 2025 (Italy)
- Breast Cancer: Screening, Diagnosis, and Treatment - CANCER2025 (Netherlands)
- Cancer & Stem Cell Therapy - Cancer Meeting Summit 2025 (France)
- Cancer Awareness and Survival - Cancer Meeting Summit 2025 (France)
- Cancer Awareness and Survival - World Cancer-2025 (Spain)
- Cancer Biology - CANCER BIOLOGY- 2025 (Italy)
- Cancer Biology and Drug Delivery - Cancer Research 2025 (Spain)
- Cancer Biomarkers - Cancer Meeting Summit 2025 (France)
- Cancer Biopsy - Cancer Meeting Summit 2025 (France)
- Cancer Causes and Risk Factors - Cancer Meeting Summit 2025 (France)
- Cancer Cell Biology & Geneti - Cancer Meeting Summit 2025 (France)
- Cancer Cell Biology & Genetics - World Cancer-2025 (Spain)
- Cancer Clinical Trials - Cancer Research 2025 (Spain)
- Cancer Control and Survivorship Care - CANCER BIOLOGY- 2025 (Italy)
- Cancer Early Detection, Diagnosis and Prognosis - Cancer Meeting Summit 2025 (France)
- Cancer Epidemiology - World Cancer-2025 (Spain)
- Cancer Epidemiology and Biomarkers - Preventive Oncology 2025 (Italy)
- Cancer Epidemiology and Public Health - CANCER BIOLOGY- 2025 (Italy)
- Cancer Epidemiology, Screening, Diagnosis & Prognosis - Cancer Research 2025 (Spain)
- Cancer Genetics and Epigenetics - Cancer Research 2025 (Spain)
- Cancer Genomics and Epigenetics - CANCER BIOLOGY- 2025 (Italy)
- Cancer Genomics and Precision Oncology - Preventive Oncology 2025 (Italy)
- Cancer Immunology & Immunotherapy - World Cancer-2025 (Spain)
- Cancer Immunology and Immunotherapy - Preventive Oncology 2025 (Italy)
- Cancer Immunology and Immunotherapy - CANCER BIOLOGY- 2025 (Italy)
- Cancer immunotherapy: Car T Cell Technology - Cancer Research 2025 (Spain)
- Cancer Metabolism and Nutritional Interventions - CANCER2025 (Netherlands)
- Cancer Nanotechnology - World Cancer-2025 (Spain)
- Cancer Pharma Industry - Cancer Research 2025 (Spain)
- Cancer Pharmacology - World Cancer-2025 (Spain)
- Cancer Pharmacology and Drug Development - CANCER BIOLOGY- 2025 (Italy)
- Cancer Prevention & Research - Cancer Meeting Summit 2025 (France)
- Cancer Prevention and Risk Reduction - CANCER2025 (Netherlands)
- Cancer Preventive Vaccines: Oncolytic Therapy & Others - Cancer Research 2025 (Spain)
- Cancer Screening & Chemotherapy - Cancer Meeting Summit 2025 (France)
- Cancer Stem Cells and Therapeutics - CANCER BIOLOGY- 2025 (Italy)
- Cancer Stem Cells and Therapeutics - CANCER BIOLOGY- 2025 (Italy)
- Cancer Stem Cells and Tumor Biology - CANCER2025 (Netherlands)
- Cancer Vaccines - Cancer Meeting Summit 2025 (France)
- Cancer Vaccines and Preventive Strategies - CANCER BIOLOGY- 2025 (Italy)
- Cancer Vaccinology and Preventive Vaccines - CANCER2025 (Netherlands)
- Cancer: Psychological & Social factors - World Cancer-2025 (Spain)
- Cancers & Stem Cell therapy - World Cancer-2025 (Spain)
- Cancers Biomarkers - World Cancer-2025 (Spain)
- Cancers Biopsy - World Cancer-2025 (Spain)
- Cancers Chemotherapy - World Cancer-2025 (Spain)
- Cancers Metabolomics - World Cancer-2025 (Spain)
- Cancers Metastasis - World Cancer-2025 (Spain)
- Cancers Prevention & Research - World Cancer-2025 (Spain)
- Cancers Therapy & Treatments - World Cancer-2025 (Spain)
- Cancers Vaccines - World Cancer-2025 (Spain)
- Cancers: lifestyle Connection and Nutrition - World Cancer-2025 (Spain)
- CAR-T Cell Therapy and Cell-Based Treatments - CANCER2025 (Netherlands)
- Case Studies - Breast Cancer 2025 (Italy)
- Cell and Gene Therapy for Cancer - Cancer Research 2025 (Spain)
- Circulating Tumor Cell (CTC) - Cancer Research 2025 (Spain)
- Clinical Trials and Regulatory Aspects in Oncology - CANCER2025 (Netherlands)
- Complementary & Alternate Methods and Cancer - World Cancer-2025 (Spain)
- CRISPR/Cas9 in CSC Research - Cancer Stem Cells 2025 (Netherlands)
- CSC and Immunoediting - Cancer Stem Cells 2025 (Netherlands)
- CSC Biomarkers for Early Detection - Cancer Stem Cells 2025 (Netherlands)
- CSC Fate Determination and Differentiation - Cancer Stem Cells 2025 (Netherlands)
- CSC Heterogeneity in Tumors - Cancer Stem Cells 2025 (Netherlands)
- CSC Metabolism and Energy Pathways - Cancer Stem Cells 2025 (Netherlands)
- CSC Niche and Hypoxia - Cancer Stem Cells 2025 (Netherlands)
- CSC Plasticity and Tumor Progression - Cancer Stem Cells 2025 (Netherlands)
- CSC-Derived Exosomes and Communication - Cancer Stem Cells 2025 (Netherlands)
- CSC-Driven Angiogenesis - Cancer Stem Cells 2025 (Netherlands)
- CSC-Driven Resistance to Radiotherapy - Cancer Stem Cells 2025 (Netherlands)
- CSC-Mediated Immunosuppression - Cancer Stem Cells 2025 (Netherlands)
- CSCs and Tumor Microenvironment - Cancer Stem Cells 2025 (Netherlands)
- Diagnostic Imaging in Cancer: Innovations and Future Directions - Preventive Oncology 2025 (Italy)
- Diet and Lifestyle Effects on Breast Cancer - Breast Cancer 2025 (Italy)
- DNA Damage, Mutation and Cancer - Cancer Meeting Summit 2025 (France)
- Drug Resistance Mechanisms in CSCs - Cancer Stem Cells 2025 (Netherlands)
- Early Detection and Screening Innovations - CANCER2025 (Netherlands)
- Environmental Carcinogens and Cancer Epidemiology - CANCER2025 (Netherlands)
- Epidemiology of Breast Cancer and Risk Factors - Breast Cancer Summit 2025 (Italy)
- Epidemiology of Breast Cancer and Risk Factors - Breast Cancer 2025 (Italy)
- Epigenetics and CSC Regulation - Cancer Stem Cells 2025 (Netherlands)
- Gene Editing & CRISPR in Cancer - World Cancer-2025 (Spain)
- Genetic and Environmental Factors in Cancer Development - Preventive Oncology 2025 (Italy)
- Genomics and Cancer Epigenetics - CANCER2025 (Netherlands)
- Gynaecological Cancers - Cancer Meeting Summit 2025 (France)
- Immunotherapy and Cancer Vaccines - CANCER2025 (Netherlands)
- Immunotherapy and CSCs - Cancer Stem Cells 2025 (Netherlands)
- Inflammation and CSC Activation - Cancer Stem Cells 2025 (Netherlands)
- Inflammatory Breast Cancer - Breast Cancer Summit 2025 (Italy)
- Inflammatory Breast Cancer - Breast Cancer 2025 (Italy)
- Innovations in Cancer Diagnostics and Early Detection - Preventive Oncology 2025 (Italy)
- Innovations in Cancer Research - CANCER BIOLOGY- 2025 (Italy)
- Liquid Biopsy and Non-Invasive Diagnostics - CANCER2025 (Netherlands)
- Male Breast Cancer Research - Breast Cancer Summit 2025 (Italy)
- Male Breast Cancer Research - Breast Cancer 2025 (Italy)
- Mammography - Breast Cancer 2025 (Italy)
- Metastatic breast Cancer - Breast Cancer Summit 2025 (Italy)
- Molecular Biology of Cancer - CANCER BIOLOGY- 2025 (Italy)
- Molecular Oncology: From Bench to Bedside - Preventive Oncology 2025 (Italy)
- Molecular Signaling in CSCs - Cancer Stem Cells 2025 (Netherlands)
- Nanotechnology and CSC Targeting - Cancer Stem Cells 2025 (Netherlands)
- Nanotechnology in Cancer Treatment - Cancer Research 2025 (Spain)
- Natural Products and CSC Targeting - Cancer Stem Cells 2025 (Netherlands)
- Neonatal & Pediatric Oncology - Cancer Meeting Summit 2025 (France)
- Neonatal & Pediatric Oncology - World Cancer-2025 (Spain)
- Neurological Cancers & Brain Tumors - Cancer Meeting Summit 2025 (France)
- Novel Approaches to Cancer Treatment - Cancer Research 2025 (Spain)
- Novel Screening Methods for Early Detection - Preventive Oncology 2025 (Italy)
- Nutrition, Lifestyle, and Cancer Prevention - Preventive Oncology 2025 (Italy)
- Oncologic Imaging and Diagnostics - CANCER BIOLOGY- 2025 (Italy)
- Oncology Nursing and Care - World Cancer-2025 (Spain)
- Oncology Nursing and Patient Care - CANCER2025 (Netherlands)
- Oncology Nursing Care - Cancer Meeting Summit 2025 (France)
- Oncology Radiology, Nanotechnology - Cancer Meeting Summit 2025 (France)
- Oncolytic Virus and Cancer - Cancer Meeting Summit 2025 (France)
- Organ Specific Cancer - Cancer Meeting Summit 2025 (France)
- Organ Specific Cancer - Cancer Research 2025 (Spain)
- Organ-defined Cancers - World Cancer-2025 (Spain)
- Palliative Care and Quality of Life - CANCER2025 (Netherlands)
- Pediatric Oncology - CANCER BIOLOGY- 2025 (Italy)
- Pediatric Oncology Innovations - CANCER2025 (Netherlands)
- Personalized Cancer Medicine and Targeted Therapy - Preventive Oncology 2025 (Italy)
- PET Scans in High-Risk Populations for Cancer Prevention - Preventive Oncology 2025 (Italy)
- Pharmacovigilance and Drug Safety in Oncology - CANCER2025 (Netherlands)
- Precision Cancers Medicinal Drug & Oncology - World Cancer-2025 (Spain)
- Precision Medicine and Immuno-Oncology - Cancer Research 2025 (Spain)
- Precision Oncology and Personalized Medicine - CANCER2025 (Netherlands)
- Preventive Oncology in Low- and Middle-Income Countries - Preventive Oncology 2025 (Italy)
- Psychosocial Oncology and Mental Health - CANCER2025 (Netherlands)
- Public Health Strategies in Reducing Cancer Burden - Preventive Oncology 2025 (Italy)
- Radiation Oncology and Radiotherapy Advances - CANCER2025 (Netherlands)
- Radiation Therapy - CANCER BIOLOGY- 2025 (Italy)
- Radiology - Breast Cancer 2025 (Italy)
- Radiology & Imaging in Cancer Diagnosis & Therapy - Cancer Research 2025 (Spain)
- Rare Cancers and Orphan Drugs - CANCER2025 (Netherlands)
- Role of AI and Machine Learning in Cancer Diagnosis - Preventive Oncology 2025 (Italy)
- Role of CSCs in Metastasis - Cancer Stem Cells 2025 (Netherlands)
- Role of EMT in CSC Plasticity - Cancer Stem Cells 2025 (Netherlands)
- Surgical and Clinical Oncology - Cancer Meeting Summit 2025 (France)
- Surgical Oncology and Minimally Invasive Techniques - CANCER2025 (Netherlands)
- Targeted Cancer Therapy - Cancer Research 2025 (Spain)
- Targeted Therapy and Molecular Diagnostics - CANCER2025 (Netherlands)
- Targeting CSC Dormancy - Cancer Stem Cells 2025 (Netherlands)
- Targeting CSC-Specific Surface Markers - Cancer Stem Cells 2025 (Netherlands)
- Telemedicine and Digital Health in Oncology - CANCER2025 (Netherlands)
- Therapy Resistance and CSCs - Cancer Stem Cells 2025 (Netherlands)
- Tumor Microenvironment - CANCER BIOLOGY- 2025 (Italy)
- Tumor Microenvironment and Its Role in Cancer Progression - Preventive Oncology 2025 (Italy)
- Tumor Microenvironment and Metastasis - CANCER2025 (Netherlands)
- Tumor Virology, Immunology & Mobile Pathology - World Cancer-2025 (Spain)
- Tumour Virology, Immunology & Cellular Pathology - Cancer Meeting Summit 2025 (France)